{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T09:37:10Z","timestamp":1793093830143,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd014672","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000}}],"reference-count":118,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd014672.pub2","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:29:54Z","timestamp":1792596594000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of allogeneic hematopoietic stem cell transplantation in adults with mature T-cell lymphomas"],"prefix":"10.1002","volume":"2026","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0639-7044","authenticated-orcid":false,"given":"Laura Diana","family":"Stocker","sequence":"additional","affiliation":[{"name":"Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; Faculty of Medicine and University Hospital Cologne, University of Cologne; Cologne Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Thielecke","sequence":"additional","affiliation":[{"name":"Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; Faculty of Medicine and University Hospital Cologne, University of Cologne; Cologne Germany"},{"name":"General Practice, Gemeinschaftspraxis Dr. Kaiser und Muders; Herdorf Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantin","family":"Schmitz","sequence":"additional","affiliation":[{"name":"Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; Faculty of Medicine and University Hospital Cologne, University of Cologne; Cologne Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina","family":"Monsef","sequence":"additional","affiliation":[{"name":"Cochrane ESU Germany\/UK, Cochrane Haematology, Institute of Public Health; Faculty of Medicine and University Hospital Cologne, University of Cologne; Cologne Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4744-6192","authenticated-orcid":false,"given":"Nicole","family":"Skoetz","sequence":"additional","affiliation":[{"name":"Cochrane ESU Germany\/UK, Cochrane Haematology, Institute of Public Health; Faculty of Medicine and University Hospital Cologne, University of Cologne; Cologne Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7473-7476","authenticated-orcid":false,"given":"Marco","family":"Herling","sequence":"additional","affiliation":[{"name":"Department for Hematology, Cell Therapy, Hemostaseology and Infectious Diseases; Faculty of Medicine and University Hospital Leipzig, University of Leipzig; Leipzig Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,10,21]]},"reference":[{"key":"10.1002\/14651858.CD014672.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.12688\/f1000research.12573.1","article-title":"Recent advances in understanding and managing T-cell lymphoma","volume":"6","author":"Yi","year":"2017","journal-title":"F1000Research"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1720\u201348","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"16","key":"10.1002\/14651858.CD014672.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","volume":"133","author":"Willemze","year":"2019","journal-title":"Blood"},{"issue":"25","key":"10.1002\/14651858.CD014672.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","author":"International T-cell lymphoma project","year":"2008","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/ajh.24791","article-title":"The aggressive peripheral T-cell lymphomas: 2017","volume":"92","author":"Armitage","year":"2017","journal-title":"American Journal of Hematology"},{"issue":"14","key":"10.1002\/14651858.CD014672.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A predictive model of aggressive non-Hodgkin's lymphomas. The international non-Hodgkin's lymphoma prognostic factors project","volume":"329","author":"Shipp","year":"1993","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD014672.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.ctrv.2014.08.001","article-title":"Therapeutic options in relapsed or refractory peripheral T-cell lymphoma","volume":"40","author":"Coiffier","year":"2014","journal-title":"Cancer Treatment Reviews"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0008|cit8","first-page":"439\u201356","article-title":"Aggressive T-cell lymphomas: 2024: updates on diagnosis, risk stratification, and management","volume":"99","author":"Ong","year":"2023","journal-title":"American Journal of Hematology"},{"issue":"1","key":"10.1002\/14651858.CD014672.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1053\/j.seminhematol.2013.11.010","article-title":"Allogeneic transplantation in T-cell lymphomas","volume":"51","author":"Schmitz","year":"2014","journal-title":"Seminars in Hematology"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"e542\u201354","DOI":"10.1016\/S2352-3026(25)00073-0","article-title":"Allogeneic haematopoietic cell transplantation in peripheral T-cell lymphoma: recommendations from the EBMT Practice Harmonisation and Guidelines Committee","volume":"12","author":"Damaj","year":"2025","journal-title":"Lancet Haematology"},{"issue":"18","key":"10.1002\/14651858.CD014672.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1182\/blood-2010-02-270785","article-title":"Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group","volume":"116","author":"Schmitz","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1002\/14651858.CD014672.pub2-BIB0012|cit12","first-page":"139","article-title":"Treatment strategies for relapsed or refractory peripheral T-cell lymphomas","volume":"2","author":"Kim","year":"2010","journal-title":"European Journal of Clinical & Medical Oncology"},{"issue":"8","key":"10.1002\/14651858.CD014672.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1200\/JCO.18.00501","article-title":"Revised adult T-cell leukemia-lymphoma international consensus meeting report","volume":"37","author":"Cook","year":"2019","journal-title":"Journal of Clinical Oncology"},{"issue":"5","key":"10.1002\/14651858.CD014672.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"v108","DOI":"10.1093\/annonc\/mdv201","article-title":"Peripheral T-cell lymphomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"26","author":"D\u2019Amore","year":"2015","journal-title":"Annals of Oncology"},{"issue":"14","key":"10.1002\/14651858.CD014672.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1132\u201343","DOI":"10.1182\/blood.2019000402","article-title":"Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia","volume":"134","author":"Staber","year":"2019","journal-title":"Blood"},{"issue":"11","key":"10.1002\/14651858.CD014672.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1200\/JCO.2004.12.050","article-title":"Graft-versus-lymphoma effect in relapsed peripheral T-cell Non-Hodgkin\u2019s lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells","volume":"22","author":"Corradini","year":"2004","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"520\u20136","DOI":"10.1038\/leu.2011.240","article-title":"Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed\/refractory peripheral T-cell lymphomas: long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect","volume":"26","author":"Dodero","year":"2012","journal-title":"Leukemia"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"2316\u201323","DOI":"10.1038\/sj.leu.2404822","article-title":"Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas: pre-transplant disease status and histotype heavily influence outcome","volume":"21","author":"Corradini","year":"2007","journal-title":"Leukemia"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1365-2141.2009.07886.x","article-title":"The allogeneic graft-versus-cancer effect","volume":"147","author":"Ringden","year":"2009","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000358579","article-title":"Allogeneic stem-cell transplantation for peripheral T-cell lymphoma: a systemic review and meta-analysis","volume":"133","author":"Wei","year":"2015","journal-title":"Acta Haematologica"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0021|cit21","unstructured":"Higgins JP Lasserson T Thomas J Flemyng E Churchill R Methodological expectations of Cochrane intervention reviews. Cochrane: London, Version August 2023 Available from https:\/\/community.cochrane.org\/mecir-manual"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD014672.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/ije\/dyg313","article-title":"Commentary: Mendelian randomization\u2014an update on its use to evaluate allogeneic stem cell transplantation in leukaemia","volume":"33","author":"Wheatley","year":"2004","journal-title":"International Journal of Epidemiology"},{"issue":"27","key":"10.1002\/14651858.CD014672.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1200\/JCO.1998.16.1.139","article-title":"Interpreting the significance of changes in health-related quality-of-life scores","volume":"1","author":"Osoba","year":"1998","journal-title":"Journal of Clinical Ongology"},{"issue":"5","key":"10.1002\/14651858.CD014672.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European-American Classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0027|cit27","unstructured":"Lefebvre C Glanville J Briscoe S Littlewood A Marshall C Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0028|cit28","unstructured":"Covidence Veritas Health Innovation 2025"},{"issue":"10","key":"10.1002\/14651858.CD014672.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"The Prisma Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0030|cit30","unstructured":"Higgins JP Eldridge S Li T Chapter 23: Including variants on randomized trials. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0032|cit32","unstructured":"Higgins JP Savovi\u0107 J Page MJ Elbers RG Sterne JA Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD014672.pub2-BIB0034|cit34","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008205.pub3","article-title":"Hepatic late adverse effects after antineoplastic treatment for childhood cancer","author":"Mulder","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0035|cit35","unstructured":"Deeks JJ Higgins JP Altman DG Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0038|cit38","unstructured":"Page MJ Higgins JP Sterne JA Chapter 13: Assessing risk of bias due to missing results in a synthesis. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0039|cit39","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2026"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0040|cit40","unstructured":"Reeves BC Deeks JJ Higgins JP Shea B Tugwell P Wells GA Chapter 24: Including non-randomized studies on intervention effects. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bbmt.2018.08.025","article-title":"The impact of advanced patient age on mortality after allogeneic hematopoietic cell transplantation for non-hodgkin lymphoma: a retrospective study by the European Society for Blood and Marrow Transplantation Lymphoma Working Party","volume":"25","author":"Kyriakou","year":"2019","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-2141.2005.05755.x","article-title":"Allogeneic haematopoietic stem-cell transplantation for relapsed and refractory aggressive histology non-Hodgkin lymphoma","volume":"131","author":"Doocey","year":"2005","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0043|cit43","volume-title":"Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","author":"Harris","year":"2001"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0044|cit44","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Campo","year":"2008"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0045|cit45","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2017"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0046|cit46","unstructured":"GRADEpro Guideline Development Tool McMaster University (developed by Evidence Prime) 2026"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0047|cit47","unstructured":"Sch\u00fcnemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jclinepi.2016.01.032","article-title":"GRADE Guidelines: 16. Grade evidence to decision frameworks for tests in clinical practice and public health","volume":"76","author":"Sch\u00fcnemann","year":"2016","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD014672.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1182\/blood-2008-10-182592","article-title":"Quality of life after allogeneic hematopoietic cell transplantation","volume":"114","author":"Pidala","year":"2009","journal-title":"Blood"},{"issue":"11","key":"10.1002\/14651858.CD014672.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1200\/JCO.2004.12.050","article-title":"Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells","volume":"22","author":"Corradini","year":"2004","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1941\u201350","DOI":"10.1016\/S0140-6736(23)00329-X","article-title":"Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study","volume":"401","author":"Masson","year":"2023","journal-title":"Lancet"},{"issue":"7","key":"10.1002\/14651858.CD014672.pub2-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41571-023-00777-8","article-title":"HSCT prolongs remission of high-risk CTCLs","volume":"20","author":"Killock","year":"2023","journal-title":"Nature Reviews Clinical Oncology"},{"issue":"10392","key":"10.1002\/14651858.CD014672.pub2-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1016\/S0140-6736(23)00631-1","article-title":"Cogent data on allogeneic haematopoietic stem-cell transplantation efficacy in advanced cutaneous T-cell lymphoma","volume":"401","author":"Iqbal","year":"2023","journal-title":"Lancet"},{"issue":"22","key":"10.1002\/14651858.CD014672.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1200\/JCO-25-00183","article-title":"Overall survival after allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score-matched controlled prospective study","volume":"43","author":"Masson","year":"2025","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0055|cit55","unstructured":"Auto-versus Allotransplantation in T-NHL - Autologous or allogeneic transplantation following conventional chemotherapy in younger patients (18-60 yrs.) with mature (peripheral) T-cell lymphoma - AATT https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2007-001052-39\/results"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/hon.64_2629","article-title":"First-line therapy of T-cell lymphoma: allogeneic or autologous transplantation for consolidation-final results of the AATT study","volume":"37 (Suppl 2)","author":"Tournilhac","year":"2019","journal-title":"Hematological Oncology"},{"issue":"15 (Suppl)","key":"10.1002\/14651858.CD014672.pub2-BIB0057|cit57","first-page":"8507","article-title":"Allogeneic or autologous transplantation as first-line therapy for younger patients with peripheral T-cell lymphoma: results of the interim analysis of the AATT trial","volume":"33","author":"Schmitz","year":"2015","journal-title":"Journal of Clinical Oncology"},{"issue":"16 (Suppl)","key":"10.1002\/14651858.CD014672.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"7534","DOI":"10.1200\/JCO.2022.40.16_suppl.7534","article-title":"Standard chemotherapy followed by allogeneic or autologous transplantation: the role of allogeneic transplantation in the AATT study","volume":"40","author":"Schmitz","year":"2022","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"3788","DOI":"10.1200\/JCO.24.00554","article-title":"Long-term follow-up of the prospective randomized AATT study (autologous or allogeneic transplantation in patients with peripheral T-cell lymphoma)","volume":"42","author":"Tournilhac","year":"2024","journal-title":"Journal of Clinical Oncology"},{"issue":"19","key":"10.1002\/14651858.CD014672.pub2-BIB0060|cit60","first-page":"2646","article-title":"A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL","volume":"137","author":"Schmitz","year":"2021","journal-title":"Blood"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0061|cit61","unstructured":"Auto-versus allotransplantation in T-NHL \u2014 autologous or allogeneic transplantation following conventional chemotherapy in younger patients (18\u201360 yrs.) with mature (peripheral) T-cell lymphoma \u2014 AATT https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=EUCTR2007-001052-39-DE"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0062|cit62","first-page":"117","article-title":"Allogeneic or autologous transplantation as firstline therapy for younger patients with peripheral T-cell lymphoma-results of the interim analysis of the AATT trial","volume":"1","author":"Schmitz","year":"2015","journal-title":"Hematological Oncology"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0063|cit63","unstructured":"Tournilhac O Altmann B Friedrichs B Bouabdallah K Cartron G Nickelsen M Allogeneic transplantation in T-cell lymphoma: lessons from the AATT study 17th International Conference on Malignant Lymphoma; 2023 June 13-17; Lugano (Switzerland) 2023 512 3"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"Abstract 7503","DOI":"10.1200\/JCO.2019.37.15_suppl.7503","article-title":"First-line therapy of T-cell lymphoma: allogeneic or autologous transplantation for consolidation \u2014 Final results of the AATT study","volume":"37","author":"Schmitz","year":"2019","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0065|cit65","unstructured":"Keimyung University Dongsan Medical Center; Otsuka Pharmaceutical CoLtd Allogeneic stem cell transplantation in relapsed\/refractory T-, NK\/T-cell lymphomas ClinicalTrials.gov 2016"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0066|cit66","unstructured":"National Cancer Institute; National Institutes of Health Clinical Center Allogeneic hematopoietic cell transplantation for peripheral t cell lymphoma ClinicalTrials.gov 2019"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0067|cit67","unstructured":"Reduced intensity conditioning with thiotepa combined with busulfan, fludarabine and cytarabine in allogeneic hematopoietic stem cell transplantation in the treatment of relapsed or refractory peripheral T-cell lymphoma Clinicaltrials.gov 2024"},{"issue":"7","key":"10.1002\/14651858.CD014672.pub2-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.3324\/haematol.2017.186577","article-title":"The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective, International T-Cell Project","volume":"103","author":"Bellei","year":"2018","journal-title":"Haematologica"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/hon.2228","article-title":"Clinical characteristics and patterns of care of patients (PTS) with peripheral t-cell lymphoma (PTCLs) according to age at time of diagnosis: A t-cell project snapshot","volume":"1)","author":"Bellei","year":"2015","journal-title":"Hematological Oncology"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0070|cit70","doi-asserted-by":"crossref","unstructured":"Bellei M Foss FM Horwitz SM Marcheselli L Kim WS Cabrera ME The outcome of patients with primary refractory or relapsed peripheral T-cell lymphoma: Analysis of 1020 cases registered in the prospective T-cell project Blood. Conference: 58th Annual Meeting of the American Society of Hematology, ASH 2016","DOI":"10.1182\/blood.V128.22.921.921"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0071|cit71","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/hon.2228","article-title":"The role of transplant in the treatment of peripheral T-cell lymphomas (PTCLs): An analysis from the T-cell project database","volume":"1)","author":"Horwitz","year":"2015","journal-title":"Hematological Oncology"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0072|cit72","first-page":"624","article-title":"Long-term follow-up of a prospective trial of intensified chemo-immunotherapy with autologous or allogeneic stem cell transplantation in patients affected by peripheral T-cell lymphoma","volume":"102 (Supplement","author":"Corradini","year":"2017","journal-title":"Haematologica"},{"issue":"9","key":"10.1002\/14651858.CD014672.pub2-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1038\/leu.2014.79","article-title":"Intensified chemo-immunotherapy with or without stem cell transplantation in newly diagnosed patients with peripheral T-cell lymphoma","volume":"28","author":"Corradini","year":"2014","journal-title":"Leukemia"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0074|cit74","doi-asserted-by":"crossref","unstructured":"Corradini P Vitolo U Rambaldi A Miceli R Patriarca F Gallamini A Intensified chemo-immunotherapy including up-front autologous or allogeneic stem cell transplantation (SCT) for young patients with newly diagnosed peripheral T-cell lymphomas: Final results of a phase II multicenter prospective clinical trial Blood. Conference: 54th Annual Meeting of the American Society of Hematology, ASH 2012","DOI":"10.1182\/blood.V120.21.1984.1984"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0075|cit75","first-page":"252","article-title":"Intensified chemo-immunotherapy for adult patients affected by nodal peripheral t-cell lymphomas (PTCLS) at diagnosis: Final results of a phase ii multicenter prospective trial","volume":"1)","author":"Corradini","year":"2013","journal-title":"Haematologica"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0076|cit76","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/hon.2057","article-title":"Intensified chemo-immunotherapy for patients affected by nodal peripheral T-cell lymphomas (PTCLS) at diagnosis: Final results of a phase II multicentre prospective trial","volume":"1)","author":"Corradini","year":"2013","journal-title":"Hematological Oncology"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0077|cit77","first-page":"624-625","article-title":"Long-term follow-up of a prospective trial of intensified chemo-immunotherapy with autologous or allogeneic stem cell transplantation in patients affected by peripheral T-cell lymphoma","volume":"102","author":"Corradini","year":"2017","journal-title":"Haematologica. Conference: 22th Congress of the European Hematology Association. Spain"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0078|cit78","unstructured":"Intensive chemo-immunotherapy as first line treatment in adult patients with peripheral T- cell lymphoma https:\/\/ClinicalTrials.gov\/show\/NCT01679860 2006"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0079|cit79","doi-asserted-by":"crossref","unstructured":"Fukushima T Tsukasaki K Machida R Maruyama D Makita S Kusumoto S Upfront allo-HSCT after intensive chemotherapy for untreated aggressive ATL: JCOG0907, a single-arm, phase 3 trial Journal of Clinical Oncology 2024","DOI":"10.21203\/rs.3.rs-8095067\/v1"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0080|cit80","unstructured":"Single-arm confirmatory trial for the strategy including allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma(JCOG0907, ATL-alloHSCT) http:\/\/www.who.int\/trialsearch\/Trial2.aspx?TrialID=JPRN-UMIN000004147 2010"},{"issue":"12","key":"10.1002\/14651858.CD014672.pub2-BIB0081|cit81","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1093\/annonc\/mdv473","article-title":"Allogeneic stem-cell transplantation in patients with cutaneous lymphoma: updated results from a single institution","volume":"26","author":"Hosing","year":"2015","journal-title":"Annals of Oncology"},{"issue":"14","key":"10.1002\/14651858.CD014672.pub2-BIB0082|cit82","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1200\/JCO.2009.25.8301","article-title":"Total skin electron beam and non-myeloablative allogeneic hematopoietic stem-cell transplantation in advanced mycosis fungoides and Sezary syndrome","volume":"28","author":"Duvic","year":"2010","journal-title":"Journal of Clinical Oncology"},{"issue":"5","key":"10.1002\/14651858.CD014672.pub2-BIB0083|cit83","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1016\/j.clml.2014.09.013","article-title":"Long-term complete responses to combination therapies and allogeneic stem cell transplants in patients with sezary syndrome","volume":"15","author":"Polansky","year":"2015","journal-title":"Clinical Lymphoma, Myeloma & Leukemia"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0084|cit84","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.1038\/bmt.2012.36","article-title":"Total Skin Electron Beam radiation therapy and allogeneic haematopoietic stem cell transplantation in advanced mycosis fungoides and Sezary syndrome","volume":"1)","author":"Hosing","year":"2012","journal-title":"Bone Marrow Transplantation"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0085|cit85","unstructured":"MDAnderson Cancer Center Allogeneic transplantation in patients with cutaneous T-cell lymphoma https:\/\/ClinicalTrials.gov\/show\/NCT00506129 2003"},{"issue":"20","key":"10.1002\/14651858.CD014672.pub2-BIB0086|cit86","doi-asserted-by":"publisher","first-page":"4156","DOI":"10.1182\/bloodadvances.2021004932","article-title":"Improved survival of patients with aggressive ATL by increased use of allo-HCT: a prospective observational study","volume":"5","author":"Ito","year":"2021","journal-title":"Blood Advances"},{"issue":"2","key":"10.1002\/14651858.CD014672.pub2-BIB0087|cit87","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1093\/annonc\/mdu515","article-title":"Upfront allogeneic stem-cell transplantation for patients with nonlocalized untreated peripheral T-cell lymphoma: an intention-to-treat analysis from a single center","volume":"26","author":"Loirat","year":"2015","journal-title":"Annals of Oncology"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0088|cit88","doi-asserted-by":"crossref","unstructured":"Loirat M Chevalier P Leux C Moreau A Bossard C Guillaume T Upfront allogeneic-stem cell transplantation for patients with non-localized untreated peripheral T-Cell lymphoma: An intention-to-treat analysis from a single center Blood. Conference: 56th Annual Meeting of the American Society of Hematology, ASH 2014","DOI":"10.1182\/blood.V124.21.1217.1217"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0089|cit89","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/hon.2058","article-title":"Allogeneic-stem cell transplantation upfront in the treatment of patients with advanced T-cell lymphoma: An intention-to-treat analysis from a single institution","volume":"1)","author":"Lloirat","year":"2013","journal-title":"Hematological Oncology"},{"issue":"6","key":"10.1002\/14651858.CD014672.pub2-BIB0090|cit90","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1038\/s41409-024-02236-z","article-title":"Long term outcomes of nonmyeloablative allogeneic stem cell transplantation with TSEB TLI and ATG for Mycosis Fungoides and Sezary Syndrome","volume":"59","author":"Morris","year":"2024","journal-title":"Bone Marrow Transplantation"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0091|cit91","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/hon.2228","article-title":"Characteristics and patterns of care of patients (PTS) >=70 years with t-cell non-hodgkin lymphoma (TCL) in the United States (US)","volume":"1)","author":"Nabhan","year":"2015","journal-title":"Hematological Oncology"},{"issue":"5","key":"10.1002\/14651858.CD014672.pub2-BIB0092|cit92","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s12185-012-1177-8","article-title":"Unrelated cord blood transplantation for patients with adult T-cell leukemia\/lymphoma: experience at a single institute","volume":"96","author":"Nakamura","year":"2012","journal-title":"International Journal of Hematology"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0093|cit93","doi-asserted-by":"publisher","first-page":"viii232","DOI":"10.1093\/annonc\/mdn515","article-title":"Long-term survival of adult T-cell leukemia\/lymphoma (ATL) by reduced-intensity stem cell transplantation (RIST) from hla-matched sibling donors (MSD): The Japanese ATL-rist study","volume":"19 (S8)","author":"Okamura","year":"2008","journal-title":"Annals of Oncology"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0094|cit94","unstructured":"Park SI Horwitz SM Foss FM Pinter-Brown LC Carson KR Rosen ST The role of upfront hematopoietic stem cell transplantation (HSCT) in peripheral T-cell lymphoma (PTCL) patients in complete remission (CR) with a special focus on nodal PTCL: Report from the comprehensive oncology measures for peripheral T-cell lymphoma treatment (COMPLETE), a prospective multicenter cohort study Blood. Conference: 59th Annual Meeting of the American Society of Hematology, ASH 2017"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0095|cit95","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/hon.2228","article-title":"Characteristics and patterns of care of patients (PTS) >=70 years with t-cell non-hodgkin lymphoma (TCL) in the United States (US)","volume":"1)","author":"Nabhan","year":"2015","journal-title":"Hematological Oncology"},{"issue":"11","key":"10.1002\/14651858.CD014672.pub2-BIB0096|cit96","doi-asserted-by":"publisher","first-page":"928.e1","DOI":"10.1016\/j.jtct.2021.07.010","article-title":"A phase I\/II multicenter trial of HLA-haploidentical PBSCT with ptcy for aggressive adult t cell leukemia\/lymphoma","volume":"27","author":"Tanaka","year":"2021","journal-title":"Transplantation and Cellular Therapy"},{"issue":"18","key":"10.1002\/14651858.CD014672.pub2-BIB0097|cit97","doi-asserted-by":"publisher","first-page":"4474","DOI":"10.1182\/bloodadvances.2020001627","article-title":"Nonmyeloablative allogeneic transplantation achieves clinical and molecular remission in cutaneous T-cell lymphoma","volume":"4","author":"Weng","year":"2020","journal-title":"Blood Advances"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0098|cit98","unstructured":"Stanford University Ph II of non-myeloablative allogeneic transplantation using TLI & ATG in patients w\/ cutaneous t cell lymphoma https:\/\/ClinicalTrials.gov\/show\/NCT00896493 2009"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0099|cit99","doi-asserted-by":"crossref","unstructured":"Weng WK Armstrong R Arai S Johnston L Laport GG Lowsky R Non-myeloablative allogeneic transplantation resulting in clinical and molecular remission with low non-relapse mortality (NRM) in patients with advanced stage mycosis fungoides (MF) and sezary syndrome (SS) Blood. Conference: 56th Annual Meeting of the American Society of Hematology, ASH 2014","DOI":"10.1182\/blood.V124.21.2544.2544"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0100|cit100","doi-asserted-by":"crossref","unstructured":"Weng WK Armstrong R Arai S Sutherland K Hoppe RT Kim YH Graft-versus-lymphoma effect after non-myeloablative allogeneic transplant induces molecular remission assessed by high-throughput sequencing of T cell receptor in patients with advanced stage mycosis fungoides and sezary syndrome Blood. Conference: 53rd Annual Meeting of the American Society of Hematology, ASH 2011","DOI":"10.1182\/blood.V118.21.3114.3114"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0101|cit101","doi-asserted-by":"publisher","first-page":"4474","DOI":"10.1182\/BLOODADVANCES.2020001627","article-title":"Nonmyeloablative allogeneic transplantation achieves clinical and molecular remission in cutaneous T-cell lymphoma","volume":"4(18)","author":"Weng","year":"2020","journal-title":"Blood Advances"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1182\/blood-2023-173179","article-title":"Results of the Astral Study: A Prospective Phase II Clinical Study of the German Lymphoma Alliance to Assess the Efficacy and Toxicity of High-Dose Chemotherapy Followed By Allogeneic Stem Cell Transplantation As Treatment of Primary Progressive and Relapse","volume":"142","author":"Glass","year":"2023","journal-title":"Blood"},{"issue":"suppl. 1","key":"10.1002\/14651858.CD014672.pub2-BIB0103|cit103","first-page":"231","article-title":"A prospective phase II clinical study to assess the efficacy and toxicity of high-dose chemotherapy followed by allogeneic stem cell transplantation as treatment of primary progressive and relapsed aggressive non-hodgkin lymphoma","volume":"142","author":"Glass","year":"2019","journal-title":"Blood"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0104|cit104","doi-asserted-by":"crossref","unstructured":"ASTRAL- a clinical study to assess the efficacy and toxicity of high-dose chemotherapy https:\/\/doi.org\/10.55788\/396fc596 2019 10.55788\/396fc596","DOI":"10.55788\/396fc596"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0105|cit105","unstructured":"MDAnderson Cancer Center; National Cancer Institute Gemcitabine hydrochloride, clofarabine, and busulfan before donor stem cell transplant in treating patients with refractory B-cell or T-cell non-hodgkin lymphoma or hodgkin lymphoma ClinicalTrials.gov 2012"},{"issue":"9","key":"10.1002\/14651858.CD014672.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/sj.leu.2404306","article-title":"Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation","volume":"20","author":"Corradini","year":"2006","journal-title":"Leukemia"},{"issue":"1","key":"10.1002\/14651858.CD014672.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1200\/JCO.2008.17.4870","article-title":"Autologous stem-cell transplantation M as first-line therapy in peripheral T-cell Lymphomas: results of a prospective multicenter study","volume":"27","author":"Reimer","year":"2009","journal-title":"Journal of Clinical Oncology"},{"issue":"4","key":"10.1002\/14651858.CD014672.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/annonc\/mdl466","article-title":"The results of consolidation with autologous stem-cell transplantation in patients with peripheral T-cell lymphoma (PTCL) in first complete remission: the Spanish Lymphoma and Autologous Transplantation Group experience","volume":"18","author":"Rodriguez","year":"2007","journal-title":"Annals of Oncology"},{"issue":"12","key":"10.1002\/14651858.CD014672.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD014672.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors","volume":"18","author":"Glucksberg","year":"1974","journal-title":"Transplantation"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/annonc\/mdu515","article-title":"Upfront allogeneic stem-cell transplantation forpatients with nonlocalized untreated peripheral T-celllymphoma: an intention-to-treat analysis from a single center","volume":"26","author":"Loirat","year":"2014","journal-title":"Annals of Oncology"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0112|cit112","doi-asserted-by":"publisher","first-page":"1885\u201391","DOI":"10.1038\/leu.2014.79","article-title":"Intensified chemo-immunotherapy with or without stem cell transplantation in newly diagnosed patients with peripheral T-cell lymphoma","volume":"28","author":"Corradini","year":"2014","journal-title":"Leukemia"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"e219807","DOI":"10.1001\/jamanetworkopen.2021.9807","article-title":"Comparison of allogeneic stem cell transplant and autologous stem cell transplant in refractory or relapsed peripheral T-cell lymphomaa systematic review and meta-analysis","volume":"4","author":"Du","year":"2021","journal-title":"JAMA Network Open"},{"issue":"8","key":"10.1002\/14651858.CD014672.pub2-BIB0114|cit114","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008908","article-title":"Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T-cell lymphoma","author":"Schlaak","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bbmt.2019.08.019","article-title":"Efficacy of allogeneic hematopoietic cell transplantation in cutaneoust cell lymphoma: results of a systematic review and meta-analysis","volume":"26","author":"Iqbal","year":"2020","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"17","key":"10.1002\/14651858.CD014672.pub2-BIB0116|cit116","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-026-01783-w","article-title":"Allogeneic stem cell transplantation for major T-cell lymphoma entities: an analysis of the EBMT-lymphoma working party","volume":"19","author":"Shumilov","year":"2026","journal-title":"Journal of Hematology and Oncology"},{"key":"10.1002\/14651858.CD014672.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.annonc.2025.01.023","article-title":"Peripheral T- and natural killer-cell lymphomas: ESMO\u2013EHA Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"36","author":"d\u2019Amore","year":"2025","journal-title":"Annals of Oncology"},{"issue":"11","key":"10.1002\/14651858.CD014672.pub2-BIB0118|cit118","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1038\/s41409-025-02701-3","article-title":"Indications for haematopoietic cell transplantation and CAR-T for haematological diseases, solid tumours and immune disorders: 2025 EBMT practice recommendations","volume":"60","author":"Greco","year":"2025","journal-title":"Bone Marrow Transplantation"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T09:17:10Z","timestamp":1793092630000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD014672.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,10,21]]},"references-count":118,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd014672.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,21]]}}}